Lung Cancer
Conditions
Keywords
lung cancer
Brief summary
Participation in medical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This trial will admit a wide range of data on the clinical trial experience of lung cancer patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future lung cancer patients.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient has been diagnosed with lung cancer * Patient has self-identified as planning to enroll in an observational clinical trial * Patient is a minimum of 18 years or older
Exclusion criteria
* Pregnant or nursing patients * Inability to perform regular electronic reporting * Patient does not understand, sign, and return consent form
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of lung cancer patients who decide to enroll in a clinical trial | 3 months |
| Rate of patients who remain in a lung cancer clinical trial to trial completion | 12 months |
Contacts
Primary ContactMichael B Gill
Outcome results
None listed